Clinical Trial Update: Carbergoline for Antipsychotic Induced Hyperprolactinemia. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating carbergoline for antipsychotic-induced hyperprolactinemia in schizophrenia, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Carbergoline (cabergoline)

Snippet

Sponsor: Zealand University Hospital | Conditions: Scizophrenia | Phase 4 | Status: NOT_YET_RECRUITING